CLOZAPINE FOR THE TREATMENT OF ADOLESCENTS WITH SCHIZOPHRENIA

被引：61

作者：

BIRMAHER, B ^{[1
]}

BAKER, R ^{[1
]}

KAPUR, S ^{[1
]}

QUINTANA, H ^{[1
]}

GANGULI, R ^{[1
]}

机构：

[1] MAYVIEW STATE HOSP, BRIDGEVILLE, PA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 1992年 / 31卷 / 01期

关键词：

ADOLESCENTS; SCHIZOPHRENIA; CLOZAPINE;

D O I：

10.1097/00004583-199201000-00024

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

Despite recent reports that clozapine is useful for the treatment of chronic schizophrenics resistent to neuroleptics, no studies have been reported in adolescents with schizophrenia. Despite the risk of potentially fatal agranulocytosis, clozapine's use in adolescents may become important because of its lack of extrapyramidal side effects or association with tardive dyskinesia, and reports that suggest that schizophrenic adolescents resemble chronic adult schizophrenics. The authors report three successful trials of clozapine in adolescents with schizophrenia who did not respond to conventional neuroleptic treatment.

引用

页码：160 / 164

页数：5

共 19 条

[1] NEUROLEPTIC-INDUCED DYSKINESIAS IN CHILDREN [J].

CAMPBELL, M ;

GREGA, DM ;

GREEN, WH ;

BENNETT, WG .

CLINICAL NEUROPHARMACOLOGY, 1983, 6 (03) :207-222

[2]

CHIODO LA, 1983, J NEUROSCI, V3, P1607

[3]

CLAGHORN J, 1987, J CLIN PSYCHOPHARM, V7, P377

[4]

Gerbino C, 1980, TARDIVE DYSKINESIA R, P475

[5] CLOZAPINE AND HALOPERIDOL IN A SINGLE-BLIND CROSSOVER TRIAL - THERAPEUTIC AND BIOCHEMICAL ASPECTS IN TREATMENT OF SCHIZOPHRENIA [J].

GERLACH, J ;

KOPPELHUS, P ;

HELWEG, E ;

MONRAD, A .

ACTA PSYCHIATRICA SCANDINAVICA, 1974, 50 (04) :410-424

[6]

KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789

[7]

KLAWANS HL, 1980, AM J PSYCHIAT, V137, P900

[8]

KLEIN D, 1980, DIAGNOSIS DRUG TREAT, P88

[9]

LIEBERMAN JA, 1989, J CLIN PSYCHIAT, V50, P329

[10]

LIEBERMAN JA, 1989, PSYCHOPHARMACOL BULL, V25, P57

← 1 2 →